title: Transubstantiating commercial mushroom market with ultrasonically ultrasized mushroom powders showcasing higher bioactivity.
abstract: Mushrooms that have been restricted to fresh markets have now entered commercial and pharmaceutical markets. However, not much research has been targeted on testing the efficiency of these commercialized mushroom powders or capsules. For the first time, efforts were made to study the bioactive properties and antimicrobial properties of four predominant mushroom capsules available for commercial purposes. Then, these commercial mushroom powders were downsized to ultrasized fine powders by sonication and then their properties were compared against the commercialized ones. The results indicated that the bioactive properties and the antioxidant properties of these powders when used as marketed capsules was very less. It was following ultrasonication assisted size reduction that the cumulative bioactivity related properties got accelerated. Micro size reduction of the mushroom powders lead to significant enhancement of antiviral properties compared to antibacterial and antifungal properties. This work demonstrates that commercialization of mushroom as powders could realize higher impact through sonication assisted ultrasizing and even nanosizing.
authors: Department of Bioresource and Food Science, Konkuk University, Seoul 143-701, Korea.
authors: Xiaomin
authors: X
authors: Shang
authors: Department of Bioresource and Food Science, Konkuk University, Seoul 143-701, Korea.
authors: Gansukh
authors: G
authors: Enkhtaivan
authors: Department of Bioresource and Food Science, Konkuk University, Seoul 143-701, Korea.
authors: Sechul
authors: S
authors: Chun
authors: Department of Bioresource and Food Science, Konkuk University, Seoul 143-701, Korea. Electronic address: jejudy777@gmail.com.
authors: Judy
authors: J
authors: Gopal
authors: Department of Bioresource and Food Science, Konkuk University, Seoul 143-701, Korea. Electronic address: rational@konkuk.ac.kr.
authors: Young Soo
authors: YS
authors: Keum
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001234:Aspergillus niger / Q000187:drug effects / Q000254:growth & development; D004285:Dogs; D005524:Food Technology / Q000379:methods; D032902:Ganoderma / Q000737:chemistry*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects / Q000254:growth & development; D061985:Madin Darby Canine Kidney Cells; D008826:Microbial Sensitivity Tests; D010316:Particle Size; D010407:Penicillium / Q000187:drug effects / Q000254:growth & development; D020076:Pleurotus / Q000737:chemistry*; D011208:Powders; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000254:growth & development; D020940:Reishi / Q000737:chemistry*; D013010:Sonication; D013295:Streptococcus mutans / Q000187:drug effects / Q000254:growth & development; D055439:Tricholoma / Q000737:chemistry*
chemical_list: D000890:Anti-Infective Agents; D011208:Powders
keywords: Bioactivity; Commercial capsule; Mushroom powder; Ultrasizes; Ultrasonication